R-CHOP every 21 days for diffuse large B-cell lymphoma: Still the standard of care?

Jason Westin, Fredrick Hagemeister

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)537-540
Number of pages4
JournalJournal of Comparative Effectiveness Research
Volume2
Issue number6
DOIs
StatePublished - Nov 2013

Keywords

  • DLBCL
  • Phase III
  • R-CHOP
  • R-CHOP-14
  • R-CHOP-21
  • chemotherapy
  • dose intensity
  • lymphoma
  • review

ASJC Scopus subject areas

  • Health Policy

Cite this